Top

Published in:

Open Access 01-08-2012 | Cardiovascular Disease and Stroke (M Fink and J Safdieh, Section Editors)

International Epidemiology of Intracerebral Hemorrhage

Authors: M. Arfan Ikram, Renske G. Wieberdink, Peter J. Koudstaal

Published in: Current Atherosclerosis Reports | Issue 4/2012

Abstract

Intracerebral hemorrhage is the second most common subtype of stroke. In recent decades our understanding of intracerebral hemorrhage has improved. New risk factors have been identified; more knowledge has been obtained on previously known risk factors; and new imaging techniques allow for in vivo assessment of preclinical markers of intracerebral hemorrhage. In this review the latest developments in research on intracerebral hemorrhage are highlighted from an epidemiologic point of view. Special focus is on frequency, etiologic factors and pre-clinical markers of intracerebral hemorrhage.

Feigin VL. Stroke in developing countries: can the epidemic be stopped and outcomes improved? Lancet Neurol. 2007;6(2):94–7.PubMedCrossRef

O’Donnell M, Yusuf S. Tackling the global burden of stroke: the need for large-scale international studies. Lancet Neurol. 2009;8(4):306–7.PubMedCrossRef

Abegunde DO, Mathers CD, Adam T, et al. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet. 2007;370(9603):1929–38.PubMedCrossRef

Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol. 2007;6(2):182–7.PubMedCrossRef

Feigin VL, Lawes CM, Bennett DA, et al. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009;8(4):355–69.PubMedCrossRef

Islam MS, Anderson CS, Hankey GJ, et al. Trends in incidence and outcome of stroke in Perth, Western Australia during 1989 to 2001: the Perth Community Stroke Study. Stroke. 2008;39(3):776–82.PubMedCrossRef

Huhtakangas J, Tetri S, Juvela S, et al. Effect of increased warfarin use on warfarin-related cerebral hemorrhage: a longitudinal population-based study. Stroke. 2011;42(9):2431–5.PubMedCrossRef

Benatru I, Rouaud O, Durier J, et al. Stable stroke incidence rates but improved case-fatality in Dijon, France, from 1985 to 2004. Stroke. 2006;37(7):1674–9.PubMedCrossRef

Sivenius J, Tuomilehto J, Immonen-Raiha P, et al. Continuous 15-year decrease in incidence and mortality of stroke in Finland: the FINSTROKE study. Stroke. 2004;35(2):420–5.PubMedCrossRef

10.

Flaherty ML, Kissela B, Woo D, et al. The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology. 2007;68(2):116–21.PubMedCrossRef

11.

Khellaf M, Quantin C, d’Athis P, et al. Age-period-cohort analysis of stroke incidence in Dijon from 1985 to 2005. Stroke. 2010;41(12):2762–7.PubMedCrossRef

12.

Lovelock CE, Molyneux AJ, Rothwell PM. Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study. Lancet Neurol. 2007;6(6):487–93.PubMedCrossRef

13.

•• van Asch CJ, Luitse MJ, Rinkel GJ, et al. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9(2):167–76. A highly comprehensive review and meta-analysis on frequency and prognosis of intracerebral hemorrhage. The various studies included together cover almos three decades of study periods. PubMedCrossRef

14.

Biffi A, Battey TW, Ayres AM, et al. Warfarin-related intraventricular hemorrhage: imaging and outcome. Neurology. 2011;77(20):1840–6.PubMedCrossRef

15.

Ariesen MJ, Claus SP, Rinkel GJ, Algra A. Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke. 2003;34(8):2060–5.PubMedCrossRef

16.

•• O’Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case–control study. Lancet. 2010;376(9735):112–23. One of the largest pooled analysis investigating risk factors of intracerebral hemorrhage. PubMedCrossRef

17.

Zia E, Hedblad B, Pessah-Rasmussen H, et al. Blood pressure in relation to the incidence of cerebral infarction and intracerebral hemorrhage. Hypertensive hemorrhage: debated nomenclature is still relevant. Stroke. 2007;38(10):2681–5.PubMedCrossRef

18.

Leppala JM, Virtamo J, Fogelholm R, et al. Different risk factors for different stroke subtypes: association of blood pressure, cholesterol, and antioxidants. Stroke. 1999;30(12):2535–40.PubMedCrossRef

19.

Zhang Y, Tuomilehto J, Jousilahti P, et al. Lifestyle factors on the risks of ischemic and hemorrhagic stroke. Arch Intern Med. 2011;171(20):1811–8.PubMedCrossRef

20.

Andersen KK, Olsen TS, Dehlendorff C, Kammersgaard LP. Hemorrhagic and ischemic strokes compared: stroke severity, mortality, and risk factors. Stroke. 2009;40(6):2068–72.PubMedCrossRef

21.

Hankey GJ. Smoking and risk of stroke. J Cardiovasc Risk. 1999;6(4):207–11.PubMed

22.

Suh I, Jee SH, Kim HC, et al. Low serum cholesterol and haemorrhagic stroke in men: Korea Medical Insurance Corporation Study. Lancet. 2001;357(9260):922–5.PubMedCrossRef

23.

Suzuki K, Izumi M, Sakamoto T, Hayashi M. Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan. Cerebrovasc Dis. 2011;31(1):100–6.PubMedCrossRef

24.

Thrift AG, McNeil JJ, Forbes A, Donnan GA. Risk factors for cerebral hemorrhage in the era of well-controlled hypertension. Melbourne Risk Factor Study (MERFS) Group. Stroke. 1996;27(11):2020–5.PubMedCrossRef

25.

• Wieberdink RG, Poels MM, Vernooij MW, et al. Serum lipid levels and the risk of intracerebral hemorrhage: the Rotterdam Study. Arterioscler Thromb Vasc Biol. 2011;31(12):2982–9. One of the few recent studies to investigate lipid fractions in association with intracerebral hemorrhage as well as cerebral microbleeds. This paper provides insights into shared pathology of intracerebral hemorrhage and microbleeds with regard to lipids. PubMedCrossRef

26.

Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215–22.PubMedCrossRef

27.

•• Viswanathan A, Greenberg SM. Cerebral amyloid angiopathy in the elderly. Ann Neurol. 2011;70(6):871–80. An in-depth overview of the current insights into cerebral amyloid angiopathy. A special focus is on imaging of cerebral amyloid angiopathy, including conventional MRI and amyloid imaging. PubMedCrossRef

28.

Knudsen KA, Rosand J, Karluk D, Greenberg SM. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology. 2001;56(4):537–9.PubMedCrossRef

29.

Neau JP, Couderq C, Ingrand P, et al. Intracranial hemorrhage and oral anticoagulant treatment. Cerebrovasc Dis. 2001;11(3):195–200.PubMedCrossRef

30.

Elkind MS, Sacco RL. Direct thrombin inhibition: a novel approach to stroke prevention in patients with atrial fibrillation. Stroke. 2004;35(6):1519–22.PubMedCrossRef

31.

He J, Whelton PK, Vu B, Klag MJ. Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA. 1998;280(22):1930–5.PubMedCrossRef

32.

Rost NS, Greenberg SM, Rosand J. The genetic architecture of intracerebral hemorrhage. Stroke. 2008;39(7):2166–73.PubMedCrossRef

33.

Bellenguez C, Bevan S, Gschwendtner A, et al. Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet. 2012;44(3):328–33. doi:10.1038/ng.1081

34.

Hollingworth P, Harold D, Sims R, et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease. Nat Genet. 2011;43(5):429–35.PubMedCrossRef

35.

Biffi A, Shulman JM, Jagiella JM, et al. Genetic variation at CR1 increases risk of cerebral amyloid angiopathy. Neurology. 2012;78(5):334–41.PubMedCrossRef

36.

Hu FB, Stampfer MJ, Colditz GA, et al. Physical activity and risk of stroke in women. JAMA. 2000;283(22):2961–7.PubMedCrossRef

37.

He K, Rimm EB, Merchant A, et al. Fish consumption and risk of stroke in men. JAMA. 2002;288(24):3130–6.PubMedCrossRef

38.

Lee M, Ovbiagele B. Reno-cerebrovascular disease: linking the nephron and neuron. Expert Rev Neurother. 2011;11(2):241–9.PubMedCrossRef

39.

Lee M, Saver JL, Chang KH, et al. Impact of microalbuminuria on incident stroke: a meta-analysis. Stroke. 2010;41(11):2625–31.PubMedCrossRef

40.

Biffi A, Cortellini L, Nearnberg CM, et al. Body mass index and etiology of intracerebral hemorrhage. Stroke. 2011;42(9):2526–30.PubMedCrossRef

41.

• Greenberg SM, Vernooij MW, Cordonnier C, et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 2009;8(2):165–74. A reference paper for background, assessment, and clinical implications of cerebral microbleeds. Many studies have since been designed based on the recommendations provided in this paper. PubMedCrossRef

42.

Cordonnier C, van der Flier WM, Sluimer JD, et al. Prevalence and severity of microbleeds in a memory clinic setting. Neurology. 2006;66(9):1356–60.PubMedCrossRef

43.

Poels MM, Ikram MA, van der Lugt A, et al. Incidence of cerebral microbleeds in the general population: the Rotterdam Scan Study. Stroke. 2011;42(3):656–61.PubMedCrossRef

44.

Vernooij MW, van der Lugt A, Ikram MA, et al. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology. 2008;70(14):1208–14.PubMedCrossRef

45.

Cordonnier C, van der Flier WM. Brain microbleeds and Alzheimer’s disease: innocent observation or key player? Brain. 2011;134(Pt 2):335–44.PubMedCrossRef

46.

Baker ML, Hand PJ, Liew G, et al. Retinal microvascular signs may provide clues to the underlying vasculopathy in patients with deep intracerebral hemorrhage. Stroke. 2010;41(4):618–23.PubMedCrossRef

47.

Wieberdink RG, Ho L, Ikram MK, et al. Age-related macular degeneration and the risk of stroke: the Rotterdam study. Stroke. 2011;42(8):2138–42.PubMedCrossRef

48.

Baker ML, Hand PJ, Wong TY, et al. Retinopathy and lobar intracerebral hemorrhage: insights into pathogenesis. Arch Neurol. 2010;67(10):1224–30.PubMedCrossRef

49.

Christensen MC, Broderick J, Vincent C, et al. Global differences in patient characteristics, case management and outcomes in intracerebral hemorrhage: the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial. Cerebrovasc Dis. 2009;28(1):55–64.PubMedCrossRef

50.

Biffi A, Halpin A, Towfighi A, et al. Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy. Neurology. 2010;75(8):693–8.PubMedCrossRef

Title: International Epidemiology of Intracerebral Hemorrhage
Authors: M. Arfan Ikram
Renske G. Wieberdink
Peter J. Koudstaal
Publication date: 01-08-2012
Publisher: Current Science Inc.
Published in: Current Atherosclerosis Reports / Issue 4/2012
Print ISSN: 1523-3804
Electronic ISSN: 1534-6242
DOI: https://doi.org/10.1007/s11883-012-0252-1

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

International Epidemiology of Intracerebral Hemorrhage

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2012

Intracranial Hemorrhage in Patients with Cancer

Intracerebral Hemorrhage from Cerebral Venous Thrombosis

Anticoagulation-Related Intracranial Hemorrhages

The Pathophysiology and Clinical Presentation of Cerebral Amyloid Angiopathy

Management of Acute Hypertensive Response in Patients with Intracerebral Hemorrhage

Nonaneurysmal Subarachnoid Hemorrhage: An Update

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page